As presented in Fig. 7n, the relative probability to immunophenoscore (IPS) as well as immune checkpoint inhibitor including anti PD1/PDL1/PDL2, anti-CTLA4, and both treatments in the low CDI group was higher (P < 0.05). Here, CTLA4 is linked to clostridium difficile infection.